FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
128005 50 µg £61
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128006 500 µg £201
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  2. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  3. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  4. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  5. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  6. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  7. Zaman R, et al. 2021. Immunity. :. PubMed
  8. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  9. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  10. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  11. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  12. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  13. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  14. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  15. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  16. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  17. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  18. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  19. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  20. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  21. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  22. Dong L, et al. 2021. Cancer Cell. . PubMed
  23. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  24. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  25. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  26. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  27. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  28. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  29. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  30. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  31. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  32. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  33. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  34. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  35. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  36. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  37. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  38. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  39. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  40. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  41. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  42. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  43. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  44. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  45. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  46. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  47. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  48. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  49. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  50. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  51. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  52. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  53. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  54. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  55. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  56. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  57. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  58. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  59. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  60. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  61. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  62. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  63. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  64. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  65. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  66. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  67. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  68. He J, et al. 2019. J Clin Invest. 130. PubMed
  69. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  70. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  71. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  72. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  73. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  74. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  75. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  76. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  77. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  78. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  79. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  80. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  81. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  82. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  83. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  84. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  85. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  86. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  87. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  88. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  89. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  90. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  91. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  92. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  93. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  94. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  95. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  96. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  97. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  98. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  99. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  100. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  101. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  102. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  103. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  104. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  105. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  106. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  107. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  108. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  109. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  110. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  111. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  112. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  113. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  114. Tang S, et al. 2022. Virol J. 19:32. PubMed
  115. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  116. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  117. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  118. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  119. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  120. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  121. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  122. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  123. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  124. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  125. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  126. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  127. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  128. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  129. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  130. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  131. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  132. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  133. Jones GS, et al. 2020. mSphere. 5:. PubMed
  134. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  135. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  136. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
  137. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  138. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  139. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186135 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12/09/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Pacific Blue™ anti-mouse Ly-6C

  • APC anti-mouse Ly-6C

  • Purified anti-mouse Ly-6C

  • Biotin anti-mouse Ly-6C

  • FITC anti-mouse Ly-6C

  • Alexa Fluor® 647 anti-mouse Ly-6C

  • PE anti-mouse Ly-6C

  • PerCP/Cyanine5.5 anti-mouse Ly-6C

  • PE/Cyanine7 anti-mouse Ly-6C

  • Alexa Fluor® 488 anti-mouse Ly-6C

  • Alexa Fluor® 700 anti-mouse Ly-6C

  • APC/Cyanine7 anti-mouse Ly-6C

  • PerCP anti-mouse Ly-6C

  • Brilliant Violet 570™ anti-mouse Ly-6C

  • Brilliant Violet 421™ anti-mouse Ly-6C

  • Brilliant Violet 510™ anti-mouse Ly-6C

  • Brilliant Violet 605™ anti-mouse Ly-6C

  • Brilliant Violet 711™ anti-mouse Ly-6C

  • Purified anti-mouse Ly-6C (Maxpar® Ready)

  • Brilliant Violet 785™ anti-mouse Ly-6C

  • PE/Dazzle™ 594 anti-mouse Ly-6C

  • APC/Fire™ 750 anti-mouse Ly-6C

  • TotalSeq™-A0013 anti-mouse Ly-6C

  • Brilliant Violet 650™ anti-mouse Ly-6C

  • TotalSeq™-C0013 anti-mouse Ly-6C

  • TotalSeq™-B0013 anti-mouse Ly-6C

  • APC/Fire™ 810 anti-mouse Ly-6C Antibody

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account